Effective treatment requires addressing these complexities, often achieved by combining drugs with complementary mechanisms
Lixisenatide in type 2 diabetes: latest evidence and clinical usefulness
Other Diabetes Medications: Metformin, SGLT2 inhibitors, and DPP-4 inhibitors may be suitable alternatives
Patients with Obesity Showed High Discontinuation, Low Reinitiation of GLP-1 RAs Brian Nowosielski Researchers addressed the factors leading to and the rates of discontinuation and reinitiation of GLP-1 RAs among adults with obesity
The Institute for Clinical and Economic Review (ICER) analysis (2025) reaffirmed that even after price drops, GLP-1s consume a large share of pharmacy budgets, though at cost-effective levels relative to benefit ( [11] )
Numerous stimulants, including activation of death receptors (such as Fas), Toll-like receptors (e.g